AI-Driven Panel Design Platform Enhances Flow Cytometry Research

BD (Becton, Dickinson and Company) has released the latest version of its cloud-based research platform, aiming to accelerate experimental design and improve data quality in complex immune system and oncology studies.

The updated BD Research Cloud 7.0 integrates an artificial intelligence-based module for automated panel design, targeting technical workflows in flow cytometry — a core laboratory technique used extensively in immunology and cancer research. This release addresses a persistent bottleneck in experiment planning by providing data-driven panel recommendations and workflow support.

Addressing a Critical Step in Flow Cytometry
Flow cytometry experiments require carefully configured reagent panels to discriminate among multiple cell types and biomarkers. Traditional manual panel design is time-consuming and prone to inefficiencies that can lead to unusable or irreproducible data sets. BD’s new AI component, Horizon Panel Maker, applies algorithmic optimization to generate panel configurations within seconds from user inputs or curated validated databases. This capability reduces human intervention during experimental setup and helps streamline data workflows in immunology and oncology labs.

The platform also provides integrated visualization tools — including panel comparison tables and complexity scoring — to assist researchers in evaluating alternative configurations and understanding trade-offs in performance and reagent interactions.

Cloud Platform for Collaboration and Laboratory Operations
Beyond automated design, version 7.0 of Research Cloud serves as a collaborative, cloud-native ecosystem for managing flow cytometry operations. It supports instrument health monitoring, reagent purchasing, and team collaboration, aligning with broader digital supply chain goals in laboratory automation and scientific data management.

Technical Integration and Standards
The AI-driven panel design tool is engineered to work with BD’s FACSDiscover cell analyzers and cell sorters, enabling integrated imaging and spectral design — functions that are increasingly important for high-parameter cytometry experiments. This integrated workflow helps maintain consistency with industry standards for reproducibility and data quality in multi-parameter flow cytometry studies.

Use Cases and Research Impact
By automating a traditionally manual design step, BD’s platform can shorten experimental planning cycles and help researchers focus on assay interpretation and hypothesis testing. Laboratories engaged in immune profiling, biomarker discovery, or translational oncology research can particularly benefit from the reduction in setup time and potential for design errors.

This release reflects a broader trend of incorporating artificial intelligence into laboratory information ecosystems, enhancing both scientific productivity and data integrity.

www.bd.com